SASadeq Ali-Hasan-Al-Saegh

Sadeq Ali-Hasan-Al-Saegh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sadeq Ali-Hasan-Al-Saegh has a total of 70 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex Disparities in Outcomes After Minimally Invasive Direct CABG for Single-Vessel Disease: A Propensity Score-Matched Analysis

    by Lukman Amanov, Arian Arjomandi Rad, Sadeq Ali-Hasan-Al-Saegh, Jawad Salman, Fabio Ius, Abdullah Tahir, Thanos Athanasiou, Saeed Torabi, Stefan Rümke, Bastian Schmack, et al.

    Background: Female sex is widely regarded as an independent risk factor for adverse outcomes after conventional coronary artery bypass grafting (CABG) and is incorporated as a risk variable in EuroSCORE II. Whether this disadvantage persists in the setting of minimally invasive direct coronary artery bypass (MIDCAB), in which sternotomy and cardiopulmonary bypass are avoided, remains insufficiently characterised. We assessed sex-specific short- and long-term outcomes after MIDCAB in a single-centre cohort with extended follow-up. Methods: We retrospectively analysed 350 consecutive patients who underwent MIDCAB at Hannover Medical School between July 1999 and April 2025 (follow-up to April 2025). Eligibility criteria and heart team-applied exclusion criteria (prior left thoracotomy, unfavourable LAD anatomy, prohibitive respiratory reserve, hostile chest wall, active endocarditis, or haemodynamic instability requiring on-pump revascularization) are detailed in the Methods. Females (n = 102) and males (n = 248) were compared before and after 1:1 propensity score matching using greedy nearest-neighbour matching with a caliper of 0.2 × SD of the logit propensity score. The primary endpoint was all-cause long-term mortality; secondary endpoints included perioperative complications and in-hospital outcomes. Long-term survival was assessed by Kaplan–Meier analysis and multivariable Cox proportional hazards regression performed in the full unmatched cohort. A pre-specified subgroup analysis of long-term survival by coronary disease pattern (single-vessel vs. multivessel disease) was also performed. Results: Matching produced 100 female–male pairs with excellent covariate balance (all standardized mean differences < 0.20). MIDCAB was completed without intraoperative conversion in all patients. Thirty-day mortality was 0% in both sexes; no postoperative stroke or new requirement for dialysis occurred. New-onset atrial fibrillation (3.0% vs. 1.0%, p = 0.621), length of intensive care unit stay (median 1 day in both groups), and hospital length of stay (median 8 days in both groups) were comparable between females and males. Re-exploration for bleeding was numerically more frequent in women (5.0% vs. 0.0%; Newcombe 95% CI for the risk difference +0.3 to +11.2%; Fisher’s exact p = 0.059). At a median follow-up of 19.0 years (IQR 11.8–23.9), all-cause mortality was identical (12.0% vs. 12.0%, p = 1.000; log-rank p = 0.703). In multivariable Cox regression in the full unmatched cohort, female sex was not associated with long-term mortality (adjusted HR 0.80, 95% CI 0.38–1.70, p = 0.560); only advancing age emerged as a strong independent predictor (HR 1.10 per year, 95% CI 1.05–1.15, p < 0.001), with EuroSCORE II approaching significance (HR 1.67 per unit, 95% CI 1.00–2.82, p = 0.052). Long-term survival in patients with multivessel disease (20-year Kaplan–Meier 90.9%) was equivalent to that in single-vessel disease (92.3%; log-rank p = 0.94). Conclusions: In this propensity-matched analysis with two decades of follow-up, MIDCAB conferred equivalent perioperative safety and long-term survival in women and men. Female sex was not an independent predictor of adverse outcome. These findings support MIDCAB as a sex-neutral revascularization strategy for single-vessel and LAD-predominant coronary artery disease in the very low-risk, appropriately selected population studied, and are consistent with the most recent published MIDCAB literature.

  • Open Access

    Feasibility, Acceptability and Early Outcomes of Concomitant Aortic and Mitral Valve Surgery via a Single-Incision Right Anterior Minithoracotomy: A Retrospective Cohort Study

    by Lukman Amanov, Sadeq Ali-Hasan-Al-Saegh, Arian Arjomandi Rad, Jawad Salman, Fabio Ius, Stefan Rümke, Khalil Aburahma, Jan Dieter Schmitto, Bastian Schmack, Arjang Ruhparwar, et al.

    Background: Minimally invasive approaches for multivalve surgery have attracted increasing interest; however, data on combined aortic and mitral valve replacement or repair using via right anterior minithoracotomy remain quite limited. This study aimed to evaluate the feasibility, safety, and early outcomes of minimally invasive concomitant aortic and mitral valve replacement or repair using this approach. Methods: This retrospective study included 24 patients who underwent simultaneous aortic and mitral valve procedures via right anterior minithoracotomy. We collected preoperative, intraoperative, and postoperative data, assessing echocardiographic parameters. Early clinical outcomes, complications, and mortality rates were analyzed, with correlations between EuroSCORE II and outcomes explored. Results: The median follow-up was 412 days. All procedures were completed successfully without conversion to sternotomy. Postoperative echocardiography demonstrated a significant reduction in transvalvular gradients, with aortic mean pressure gradient decreasing from 51.3 ± 23.0 mmHg to 6.7 ± 1.7 mmHg (p < 0.001) and mitral mean pressure gradient from 19.3 ± 26.7 mmHg to 4.0 ± 1.4 mmHg (p < 0.001), while left ventricular ejection fraction remained unchanged (p = 0.67). During the study period, one patient died from a non-cardiac cause. EuroSCORE II showed a moderate positive correlation with intensive care unit length of stay (p = 0.011) but not with hospital stay or operative times. Conclusions: Minimally invasive aortic and mitral valve replacement or repair via right anterior minithoracotomy is feasible and was associated with favorable early hemodynamic and clinical outcomes in this single-center cohort.

  • Open Access

    Cardioplegia Strategies in Minimally Invasive Aortic Valve Replacement: An Inverse Probability of Treatment Weighting Analysis

    by Lukman Amanov, Sadeq Ali-Hasan-Al-Saegh, Arian Arjomandi Rad, Antonia Annegret Jauken, Prokopis-Andreas Zotos, Jawad Salman, Thanos Athanasiou, Ezin Deniz, Stefan Ruemke, Bastian Schmack, et al.

    Background and Objectives: Optimal myocardial protection during minimally invasive aortic valve replacement (MIAVR) is debated. We compared four cardioplegia strategies. Materials and Methods: Consecutive MIAVR patients (January 2010–April 2025) at a single centre were analysed retrospectively. Cardioplegia regimens were Buckberg (n = 131), Calafiore (n = 153), Custodiol HTK (n = 146) and St Thomas’ (n = 113). Because substantial baseline imbalances were present in the unadjusted cohort, inverse probability of treatment weighting (IPTW) based on a multinomial propensity score was applied to achieve covariate balance between groups. IPTW was performed using a comprehensive propensity model that incorporated (1) baseline demographic and clinical characteristics, (2) anatomical factors, including bicuspid valve morphology. Procedural time variables were assessed in secondary sensitivity analyses. After IPTW application, all variables, including procedural times, achieved balance (ASMD < 0.1). Postoperative outcomes were then compared in this fully balanced pseudo-population. The Scheffé post hoc test was performed. Results: Groups were demographically comparable except for more bicuspid valves in Buckberg. New-onset paroxysmal atrial fibrillation occurred in 31.2% (Buckberg) and 26.5% (St Thomas’) versus 7.1% (Calafiore) and 2.0% (Custodiol) (p < 0.01). Respiratory insufficiency followed a similar pattern (p = 0.02). Intensive-care and hospital stay, major complications, left-ventricular ejection fraction, and 30-day mortality (0.6–3.0%) were equivalent. Bicuspid anatomy independently prolonged operative metrics but did not influence biomarkers. Conclusions: After comprehensive inverse probability weighting that balanced groups on all baseline characteristics and anatomical factors, Calafiore and Custodiol cardioplegia strategies maintained significantly lower rates of new-onset atrial fibrillation (9.3% and 3.8% vs. 28.5% for Buckberg, p < 0.01), reduced myocardial injury biomarker release (peak CK 520 and 510 vs. 920 U/L, p < 0.01), and decreased respiratory complications (7.8% and 8.1% vs. 16.2%, p = 0.01), while mortality, stroke, and resource utilisation measures remained comparable across strategies.


  • Open Access

    Minimally invasive aortic valve replacement in morbidly obese patients: outcomes from a cohort study and pooled data analysis

    by Lukman Amanov, Sadeq Ali-Hasan-Al-Saegh, Arian Arjomandi Rad, Antonia Annegret Jauken, Thanos Athanasiou, Jawad Salman, Fabio Ius, Stefan Rümke, Bastian Schmack, Arjang Ruhparwar, et al.

    Background: In the context of cardiac surgery, morbid obesity poses several perioperative challenges. Some surgeons consider obesity a relative contraindication for minimally invasive aortic valve replacement (MIAVR) due to anatomical and technical complexities. Although MIAVR is increasingly used in standard-risk populations, evidence supporting its safety and efficacy in morbidly obese patients remains limited. Methods: This retrospective cohort consisted of 920 patients who underwent MIAVR via partial upper ministernotomy at a high-volume cardiac surgery center between 2010 and May 2025. Patients were categorized into three groups based on BMI: Class I obesity (BMI 30–35 kg/m 2 ; n = 164), Class II–III obesity (BMI > 35 kg/m 2 ; n = 54), and a non-obese control group ( n = 702). Key clinical outcomes, echocardiographic parameters, postoperative complications, and long-term mortality rates were compared. Additionally, a pairwise meta-analysis was conducted, incorporating five studies to assess outcomes of MIAVR vs. conventional full sternotomy in obese individuals. Results: There were no significant differences in most of postoperative outcomes. However, higher rates of pneumothorax and arrhythmias were observed in Class II–III obesity. Multivariate regression did not identify obesity as an independent predictor of adverse outcomes. Meta-analysis confirmed comparable operative times and a trend toward shorter ICU stays and lower respiratory complications in the MIAVR group. Conclusion: This study argues that (i) obesity alone should not delay, deter, or preclude appropriate candidates from being referred for surgical aortic valve replacement, and (ii) partial upper ministernotomy should be considered the preferred access route in obese patients, as it consistently facilitates recovery without compromising safety.

  • Open Access

    Development and Validation of an Acute Large Animal Model for Type A Aortic Dissection

    by Ezin Deniz, Sibylle Marsen, Florian Helms, Heike Krüger, Naoki Arima, Jasmin Hanke, Ali Saad Merzah, Sadeq Al-Hasan-Al-Saegh, Sara Knigge, Saman Alhowaizy, et al.

    Background: Animal models are essential for translating diagnostic and therapeutic strategies into clinical practice and offer valuable insights into the pathophysiology of diseases such as aortic dissection. This study presents a novel acute in vivo large animal model of Stanford type A aortic dissection, combining open surgical access with endovascular techniques to leverage the advantages of both. The model aims to reproducibly simulate acute dissections in swine, providing a standardized platform for evaluating diagnostics, disease mechanisms, and treatment strategies. Methods: Six pigs underwent a standardized protocol to induce aortic dissection. Arterial pressure was monitored via femoral and carotid catheterization. A conventional sternotomy was performed, followed by tangential cross-clamping of the ascending aorta and a controlled incision proximal to the brachiocephalic trunk. The intima and the media were separated using a guidewire and catheter-based technique to create a false lumen. A re-entry tear was also established to allow for controlled intraluminal access. Animals were monitored for 12 h post-intervention, with serial blood sampling. At the end of the experiment, the animals were euthanized and the aortas harvested for macroscopic and histological analysis. Results: In all 6 animals, the placement of arterial catheters in femoral and carotid arteries, as well as the sternotomy, was established without any complications. The dissection model was successfully created in 5 out of 6 animals by clinical signs such as adventitial hematoma, macroscopic wall separation and/or decreased femoral blood pressure. One animal experienced complete aortic perforation. Five animals completed the full observation period of 12 h. Conclusion: A standardized, reproducible, and robust large animal model of acute Stanford type A aortic dissection using a hybrid approach was developed. This model closely simulates the clinical and pathological features of human aortic dissection, making it a valuable tool for preclinical research in diagnostics, pathophysiology, and treatment development.

  • Open Access

    Minimally Invasive Mitral Valve Replacement in the Gray Zone: Bioprosthetic vs. Mechanical Valves in Patients Aged 50–69 Years

    by Alexander Weymann, Sadeq Ali-Hasan-Al-Saegh, Sho Takemoto, Nunzio Davide De Manna, Jan Beneke, Lukman Amanov, Fabio Ius, Ruemke Stefan, Bastian Schmack, Alina Zubarevich, et al.

    Background: Mitral valve replacement presents considerable challenges in the field of cardiothoracic surgery, particularly in patients aged 50 to 69, where the decision between bioprosthetic and mechanical valves is critical. Nevertheless, the optimal selection of prosthetic valves for candidates within this age-related gray zone remains inadequately defined, necessitating a thorough evaluation of long-term outcomes and associated risks. Objective: This study aims to assess mid-term outcomes of MIMVR in patients aged 50 to 69, comparing reoperation rates, prosthesis-related morbidity, and overall survival between bioprosthetic and mechanical valves. While many prior studies on valve choice in patients aged 50 to 69 years are derived from sternotomy cohorts, the novelty of our work lies in the exclusive focus on patients undergoing minimally invasive techniques. Methods: A retrospective analysis was conducted in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines, including 172 patients aged 50–69 years who underwent minimally invasive mitral valve replacement via right minithoracotomy at a high-volume center in Germany between 2011 and 2023. Of the 172 patients, 95 underwent MIMVR using biological prostheses, while 77 received mechanical prostheses. Comprehensive data on demographics, surgical procedures, and postoperative complications, as well as long-term outcomes, were analyzed. Results: With a mean follow-up of 7.1 years, early outcomes revealed no significant differences in 30-day mortality (7.4% for bioprosthetic vs. 2.6% for mechanical; p = 0.06). There was no significant differences in all-cause mortality at 1 year (8.4% vs. 3.9%; p = 0.22), 3-year (9.5% vs. 7.8%; p = 0.69), and 5-year (13.7% vs. 10.4%; p = 0.19), or at the longest follow-up (13.7% vs. 10.4%; p = 0.51). Kaplan–Meier analysis showed no significant difference in long-term survival between the groups (p = 0.5427). Postoperative arrhythmia occurred significantly more frequently in the biologic group compared to the mechanical group (18.9% vs. 6.5%; p = 0.01). Conclusions: For patients aged 50–69 undergoing MIMVR using a bioprosthetic or mechanical valve, the mid-term survival and incidence of reoperation and re-hospitalization were comparable up to 7 years. This provides evidence supporting the safe application of the MICS approach with either valve type in this gray-zone age group.

  • Open Access

    Challenging the Paradigm: Long-Term Outcomes in Dialysis-Dependent Patients Undergoing CABG

    by Ezin Deniz, Tonita Brunkhorst, Florian Helms, Jasmin Hanke, Ali Merzah, Sadeq Ali-Hasan Al-Saegh, Alina Zubarevich, Felix Fleissner, Issam Ismail, Gregor Warnecke, et al.

    Dialysis-dependent (DD) patients undergoing coronary artery bypass grafting (CABG) remain a particularly high-risk population with impaired outcomes despite advances in surgical techniques. In this single-center, retrospective cohort study, 97 DD patients (2010–2015) were compared with 488 non-dialysis-dependent (NDD) controls. The primary endpoint was all-cause mortality; the secondary endpoint was major adverse cardiac and cerebrovascular events (MACCE). Median follow-up was 5.4 ± 2.1 years. DD patients had significantly higher perioperative mortality (10.3% vs. 3.1%, p = 0.002) and markedly reduced overall survival (OS) (40.8% vs. 82.1% at 5 years). Dialysis dependence conferred an 8.4-fold increase in mortality risk and a 2.6-fold increase in MACCE risk. Increasing age, diabetes, and critical preoperative state were independent predictors of an adverse long-term outcome. While arterial grafting improved survival in NDD patients, no comparable benefit was observed in DD patients, possibly due to vascular calcification, limited conduit availability, and reduced graft patency. EuroSCORE II adequately predicted perioperative mortality (AUC = 0.78 in DD patients) but demonstrated poor discriminatory power for long-term survival (AUC = 0.67 at 5 years). These findings highlight the urgent need for dialysis-specific risk models. Despite poor long-term prognosis, DD patients with low-risk EuroSCORE II profiles experienced the most relative benefit from CABG.

  • Open Access

    Inflammatory and Hemolytic Responses of Microaxial Flow Pump Temporary Ventricular Assist Devices via Axillary Access in Cardiogenic Shock

    by Leonie Schmack, Sadeq Ali-Hasan-Al-Saegh, Alexander Weymann, Nikolaus Pizanis, Payam Akhyari, Alina Zubarevich, Jasmin Sarah Hanke, Aron-Frederik Popov, Arjang Ruhparwar, Tienush Rassaf, et al.

    Background and Objectives: The use of temporary left ventricular assist devices (tLVADs) for patients suffering from cardiogenic shock (CS) is becoming more common. This study examines the indications and outcomes of microaxial flow pumps (Impella®, Abiomed Inc., Danvers, MA, USA) when cannulated through the axillary artery in patients with severe CS, with a particular focus on acute phase reactions and hemolytic responses. Materials and Methods: This single-center, retrospective cohort involved patients who received microaxial Impella implantation via the axillary artery from 2020 to 2022 (n = 47). Results: Among the patients, 66% (N = 31 cases) were treated with the Impella 5.5, 25.5% (N = 12 cases) with the Impella 5.0, and 8.5% (N = 4 cases) with the Impella CP. Additionally, 28% were managed using the ECMELLA concept. The mean length of time for Impella support was 8 days. The overall 30-day survival rate was 78%, with no significant differences observed between the ECMELLA group and the various Impella types. At 30 days post-therapy, 47% of survivors no longer required mechanical support, while 26% were upgraded to a durable LVAD. Interleukin-6 (IL-6) levels were significantly lower in patients receiving Impella 5.5 (n = 17 vs. 12) immediately following implantation (p = 0.03) compared with those with smaller devices. Haptoglobin levels were significantly higher in the Impella 5.5 group (n = 17 vs. 11, p = 0.02), with overall lower rates of hemolysis (45.1%, p < 0.01). Conclusions: The mortality rate in critical CS appears reduced with axillary artery implantation of Impella devices relative to existing literature. A full-flow microaxial pump (Impella 5.5) seems advantageous regarding systemic inflammatory response syndrome (SIRS) and acute hemolysis, indicated by lower IL-6 and higher haptoglobin levels, compared with smaller Impella devices. A tailored escalation/de-escalation concept using axillary access for different mAFP types appears feasible and safe.


  • Open Access

    Optimizing Myocardial Protection in Minimally Invasive Cardiac Surgeries: A Network Comparison of Del Nido, Histidine-Tryptophan-Ketoglutarate, and Blood Cardioplegia

    by Sadeq Al-Hasan-Al-Saegh, Sho Takemoto, Stefano Benenati, Saeed Shafiei, Senol Yavuz, Mattia Galli, Florian Helms, Lukman Amanov, Nunzio Davide De Manna, Saeed Torabi, et al.

    Background/Objectives: The optimal choice of cardioplegia solution in minimally invasive cardiac surgeries (MICS) remains debated, as prolonged myocardial protection is essential to avoid interruptions to the surgical flow, which can prolong aortic cross-clamp time and cardiopulmonary bypass time, especially in the constrained surgical field. We conducted a network meta-analysis to evaluate the safety and efficacy of the del Nido (DN), histidine-tryptophan-ketoglutarate (HTK), blood cardioplegia (BC), and St. Thomas’ (STH) solutions in MICS. Methods: Medical electronic databases were thoroughly searched without time restrictions, including all types of studies except for study protocols and animal research. The final search was completed in June 2024. Subsequently, a network meta-regression was performed on both primary and secondary endpoints, utilizing R (The R Foundation for Statistical Computing, version 3.6.2) for the analysis. Meta-analyses were carried out using Review Manager software. Results: A total of 15 studies, enrolling 2282 patients, were included in the analysis. None of the comparisons showed statistically significant differences in in-hospital mortality between the four cardioplegia solutions (BC vs. HTK, OR: 3.21, 95% CI: 0.13–80.84; DN vs. HTK, OR: 1.42, 95% CI: 0.28–7.23; STH vs. HTK, OR: 1.25, 95% CI: 0.19–8.20). Conclusions: In this network meta-analysis of cardioplegia solutions in MICS, no significant differences were observed in major clinical outcomes across the solutions. Cardioplegia solutions that provide long-lasting myocardial protection with a single dose, such as DN and HTK, were found to be safely applied in MICS. DN was associated with shorter CPB times and HTK was associated with shorter hospital stays, though these differences may not have clinical implications.


  • Open Access

    Can Obesity Serve as a Barrier to Minimally Invasive Mitral Valve Surgery? Overcoming the Limitations—A Multivariate Logistic Regression Analysis

    by Sadeq Ali-Hasan-Al-Saegh, Florian Helms, Khalil Aburahma, Sho Takemoto, Nunzio Davide De Manna, Lukman Amanov, Fabio Ius, Jan Karsten, Alina Zubarevich, Bastian Schmack, et al.

    Background/Objectives: Over the past two decades, significant advancements in mitral valve surgery have focused on minimally invasive techniques. Some surgeons consider obesity as a relative contraindication for minimally invasive mitral valve surgery (MIMVS). The aim of this study is to evaluate whether the specific characteristics of obese patients contribute to increased surgical complexity and whether this, in turn, leads to worse clinical outcomes compared to non-obese patients. Furthermore, we aim to explore whether these findings could substantiate the consideration of limiting this treatment option for obese patients. We investigated the outcomes of MIMVS in obese and non-obese patients at a high-volume center in Germany staffed by an experienced surgical team well-versed in perioperative management. Methods: A total of 934 MIMVS were performed in our high-volume center in Germany from 2011 to 2023. Of these, 196 patients had a BMI of 30 or higher (obese group), while 738 patients had a BMI below 30 (non-obese group), all of whom underwent MIMVS by right minithoracotomy. Demographic information, echocardiographic assessments, surgical data, and clinical outcome parameters were collected for all patients. Results: There was no significant difference in in-hospital, 30-day, and late mortality between groups (obese vs. non-obese: 6 [3.0%] vs. 14 [1.8%], p = 0.40; 6 [3.0%] vs. 14 [1.8%], p = 0.40; 13 [6.6%] vs. 39 [5.3%], p = 0.48, respectively). Respiratory insufficiency and arrhythmia occurred more frequently in the obese group (obese vs. non-obese: 25 [12.7%] vs. 35 [4.7%], p < 0.001; 35 [17.8%] vs. 77 [10.4%], p = 0.006). Conclusions: Obesity was not associated with increased early or late mortality in patients undergoing MIMVS. However, obese patients experienced higher incidences of postoperative complications, including respiratory insufficiency, arrhythmias, delirium, and wound dehiscence. Nonetheless, a multivariate logistic regression analysis indicated that obesity itself does not contraindicate MIMVS and should not be viewed as a barrier to offering this minimally invasive approach to obese patients.